FONDAPARINUX (FON da PAR in ux) is used after knee, hip, or abdominal surgeries to prevent blood clotting. It is also used to treat existing blood clots in the lungs or in the veins.
Fondaparinux is a synthetic pentasaccharide factor Xa inhibitor. Apart from the O-
methyl group at the reducing end of the molecule, the identity and sequence of ...
Easy to read patient leaflet for fondaparinux. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Learn about the prescription medication Arixtra (Fondaparinux Sodium), drug
uses, dosage, side effects, drug interactions, warnings, reviews and patient ...
Medscape - Indication-specific dosing for Arixtra (fondaparinux), frequency-
based adverse effects, comprehensive interactions, contraindications, pregnancy
Find patient medical information for fondaparinux subcutaneous on WebMD
including its uses, side effects and safety, interactions, pictures, warnings and
Feb 17, 2015 ... Importance Fondaparinux was associated with reduced major bleeding events
and improved survival compared with low-molecular-weight ...
Jul 1, 2015 ... Fondaparinux (Arixtra) is a synthetic, highly sulfated ... The clinical use of
fondaparinux as an anticoagulant will be reviewed here [2,3].
Apr 16, 2014 ... Consumer information about the medication FONDAPARINUX - INJECTION (
Arixtra), includes side effects, drug interactions, recommended ...
Sep 26, 2014 ... The first fondaparinux administration should be given not earlier than 6 hours
following surgical closure. The injection should not be given ...